New Biochip Mimics Liver To Make Drug Discovery Faster, Easier
A team of researchers has developed a new type of biochip that emulates the metabolism of a human liver.
Rensselaer To Partner With Optum Labs Research Collaborative
Rensselaer will join as a charter partner of Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic.
Rensselaer Polytechnic Institute in U.S. and Instituto Superior Técnico of Portugal Sign Collaboration Agreement
Rensselaer and the Instituto Superior Técnico (IST) of Portugal will collaborate on a number of fronts, ranging from research to student and faculty/staff exchange.
Fighting Listeria and Other Food-Borne Illnesses With Nanobiotechnology
Engineering researchers have developed a new method to kill deadly pathogenic bacteria, including listeria, in food handling and packaging.
New Technique Enables High-Sensitivity View of Cellular Functions
Researchers have developed an ultrasensitive method for detecting sugar molecules—or glycans—coming from living organisms.
Controlling Protein Function With Nanotechnology
A new study led by nanotechnology and biotechnology experts is providing important details on how proteins in our bodies interact with nanomaterials.
Rensselaer President and Three Institute Researchers to Deliver ‘Ideas Lab’ Presentation at World Economic Forum
President Shirley Ann Jackson and three top researchers from the Institute have been invited to deliver an “Ideas Lab” presentation at the World Economic Forum.
Making Safer Chemicals: New NIH Grant Helps Researchers Study How Chemicals in Drugs and Around Us Impact Stem Cells
As more and stronger chemicals have been introduced, our basic knowledge of the broader health impact of all these chemicals has not kept up with the rapid pace of innovation.
Rensselaer Opens Doors of Biotechnology Center With First Biotechnology Public Interest Forum March 10
In an effort to increase engagement with the public, surrounding business community, and Rensselaer community in the life-saving and high-tech research ongoing at the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer, a series of regular open sessions with Rensselaer researchers will begin on March 10. The first forum, “Making Medications Safer,” will begin with a light breakfast outside the CBIS Auditorium at 8 a.m. The new series will be called the Biotechnology Public Interest Forums.